Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 174603-55-5 | MDL No. : | MFCD06656907 |
Formula : | C9H8BrFO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VHFQIJJCQTZKFK-UHFFFAOYSA-N |
M.W : | 247.06 | Pubchem ID : | 10922852 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 50.45 |
TPSA : | 37.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.05 cm/s |
Log Po/w (iLOGP) : | 1.84 |
Log Po/w (XLOGP3) : | 2.47 |
Log Po/w (WLOGP) : | 3.03 |
Log Po/w (MLOGP) : | 3.11 |
Log Po/w (SILICOS-IT) : | 2.99 |
Consensus Log Po/w : | 2.69 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -3.07 |
Solubility : | 0.21 mg/ml ; 0.000848 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.9 |
Solubility : | 0.313 mg/ml ; 0.00127 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.72 |
Solubility : | 0.0473 mg/ml ; 0.000191 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.69 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
970 mg | at 60 - 80℃; for 18 h; Inert atmosphere | Under argon 3-(2-bromo-4-fluorophenyl)propanoic acid (1 .2 g) is added in small portions to trifluoromethanesulfonic acid (15 mL) at room temperature. The mixture is stirred for 2 hours at 60°C and for 16 hours at 80°C. After cooling to room temperature the mixture is poured slowly in ice-water. The aqueous phase is extracted twice with ethyl acetate. The combined organic phases are washed with saturated aqueous Na2CO3 solution and brine. After drying (MgSO4) the solvent is evaporated. The residue is stirred with dichloromethane (40 ml_), filtered and washed with dichloromethane. The combined dichloromethane phases are concentrated to give the title compound. Yield: 970 mg; LC (method 3): tR = 0.60 min; Mass spectrum (ESI+): m/z = 229 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
33% | for 4.5 h; Reflux | To a mixture of 2-(2-bromo-4-fluoro-benzyl)-malonic acid diethyl ester (2.1 g, 6.07 mmol)and water (14 mL) was added potassium hydroxide (0.68 g, 12.14 mmol) and the reactionmixture was heated under reflux for 4.5h. The reaction mixture was cooled to RT and theethanol removed in vacuo. The aqueous residue was cooled to 0 00, acidified with conc.H2S04, and heated at 120 00 for 16h. The reaction mixture was cooled to 0 00 theprecipitated solid was collected by filtration, washed with water and dried to obtain 3-(2-bromo-4-fluoro-phenyl)-propionic acid as an off-white solid (0.5 g, 33percent).R: 0.2 (30percent EtOAc/pet-ether).1H NMR (400MHz, DMSO-d6): O 12.26 (5, 1H), 7.55-7.52 (m, 1H), 7.42-7.38 (m, 1H),7.23-7.18 (m, 1H), 2.90 (t, J= 7.8 Hz, 2H), 2.52 (t, J= 7.8 Hz, 2H). |
[ 739336-26-6 ]
2-Bromo-5-fluorophenylacetic acid
Similarity: 0.93
[ 958454-33-6 ]
2-(2-Bromo-3-fluorophenyl)acetic acid
Similarity: 0.87
[ 866862-24-0 ]
3-(3-Bromo-4-fluorophenyl)propanoic acid
Similarity: 0.86
[ 127425-80-3 ]
3-(4-Bromo-3-fluorophenyl)propanoic acid
Similarity: 0.86
[ 202000-99-5 ]
2-(3-Bromo-5-fluorophenyl)acetic acid
Similarity: 0.86
[ 739336-26-6 ]
2-Bromo-5-fluorophenylacetic acid
Similarity: 0.93
[ 958454-33-6 ]
2-(2-Bromo-3-fluorophenyl)acetic acid
Similarity: 0.87
[ 866862-24-0 ]
3-(3-Bromo-4-fluorophenyl)propanoic acid
Similarity: 0.86
[ 127425-80-3 ]
3-(4-Bromo-3-fluorophenyl)propanoic acid
Similarity: 0.86
[ 202000-99-5 ]
2-(3-Bromo-5-fluorophenyl)acetic acid
Similarity: 0.86
[ 739336-26-6 ]
2-Bromo-5-fluorophenylacetic acid
Similarity: 0.93
[ 958454-33-6 ]
2-(2-Bromo-3-fluorophenyl)acetic acid
Similarity: 0.87
[ 866862-24-0 ]
3-(3-Bromo-4-fluorophenyl)propanoic acid
Similarity: 0.86
[ 127425-80-3 ]
3-(4-Bromo-3-fluorophenyl)propanoic acid
Similarity: 0.86
[ 202000-99-5 ]
2-(3-Bromo-5-fluorophenyl)acetic acid
Similarity: 0.86
[ 739336-26-6 ]
2-Bromo-5-fluorophenylacetic acid
Similarity: 0.93
[ 958454-33-6 ]
2-(2-Bromo-3-fluorophenyl)acetic acid
Similarity: 0.87
[ 866862-24-0 ]
3-(3-Bromo-4-fluorophenyl)propanoic acid
Similarity: 0.86
[ 127425-80-3 ]
3-(4-Bromo-3-fluorophenyl)propanoic acid
Similarity: 0.86
[ 202000-99-5 ]
2-(3-Bromo-5-fluorophenyl)acetic acid
Similarity: 0.86